FDA Inspection 1096150 — Vitalant Magee Women's Hospital Site
The FDA completed an inspection of Vitalant Magee Women's Hospital Site on Jun 10, 2019 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 10, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pittsburgh, PA (United States)